Prognostic Significance of Late Gadolinium Enhancement in Fabry Disease-A Systematic Review and Meta-Analysis

Affiliations

• ¹ Department of Neuroscience, Imaging and Clinical Sciences, "G.d'Annunzio" University of Chieti-Pescara, Chieti, Italy; Department of Clinical Sciences, Lund University, Malmö, Sweden; Fondazione Villaserena per la Ricerca, Città Sant'Angelo, Italy. Electronic address: fabrizio.ricci@unich.it.
• ² Department of Neuroscience, Imaging and Clinical Sciences, "G.d'Annunzio" University of Chieti-Pescara, Chieti, Italy.
• ³ Cardio-Thoracic Surgery Unit, Heart and Vascular Centre, Maastricht University Medical Centre (MUMC), Cardiovascular Research Institute Maastricht (CARIM), Maastricht, The Netherlands.
• ⁴ Newham University Hospital, Barts Health NHS Trust, Glen Road, Plaistow, London, United Kingdom; Barts Heart Centre, Barts Health NHS Trust, West Smithfield, London, United Kingdom; NIHR Barts Biomedical Research Centre, William Harvey Research Institute, Queen Mary University, London, United Kingdom.